SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-066987
Filing Date
2023-08-14
Accepted
2023-08-14 16:01:30
Documents
51
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_phoenix.htm   iXBRL 10-Q 542191
2 CERTIFICATION f10q0623ex31-1_phoenix.htm EX-31.1 12999
3 CERTIFICATION f10q0623ex31-2_phoenix.htm EX-31.2 12540
4 CERTIFICATION f10q0623ex32-1_phoenix.htm EX-32.1 4585
5 CERTIFICATION f10q0623ex32-2_phoenix.htm EX-32.2 4679
  Complete submission text file 0001213900-23-066987.txt   3824496

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pbax-20230630.xsd EX-101.SCH 47567
7 XBRL CALCULATION FILE pbax-20230630_cal.xml EX-101.CAL 19451
8 XBRL DEFINITION FILE pbax-20230630_def.xml EX-101.DEF 235035
9 XBRL LABEL FILE pbax-20230630_lab.xml EX-101.LAB 382494
10 XBRL PRESENTATION FILE pbax-20230630_pre.xml EX-101.PRE 235954
45 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_phoenix_htm.xml XML 372669
Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40877 | Film No.: 231169573
SIC: 2836 Biological Products, (No Diagnostic Substances)